US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.410
  • +0.070+2.10%
Close Apr 29 16:00 ET
652.95MMarket Cap-8.97P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-65.98%6.17M
-26.62%1.57M
-71.25%1.34M
-62.89%1.73M
-77.09%1.53M
-53.51%18.14M
-65.65%2.15M
-21.74%4.66M
-67.34%4.65M
-46.85%6.69M
Operating revenue
-65.98%6.17M
-26.62%1.57M
-71.25%1.34M
-62.89%1.73M
-77.09%1.53M
-53.51%18.14M
-65.65%2.15M
-21.74%4.66M
-67.34%4.65M
-46.85%6.69M
Cost of revenue
Gross profit
Operating expense
-20.83%76.15M
-40.34%13.52M
-27.68%18.81M
-2.42%23.1M
-13.06%20.72M
-5.93%96.18M
-16.67%22.67M
10.46%26.01M
-15.88%23.67M
2.03%23.83M
Selling and administrative expenses
-1.63%22.11M
-7.63%4.71M
-22.34%4.54M
26.20%7.55M
-4.32%5.31M
26.02%22.48M
20.05%5.1M
67.25%5.84M
15.00%5.98M
13.49%5.55M
-General and administrative expense
-1.63%22.11M
-7.63%4.71M
-22.34%4.54M
26.20%7.55M
-4.32%5.31M
26.02%22.48M
20.05%5.1M
67.25%5.84M
15.00%5.98M
13.49%5.55M
Research and development costs
-26.68%54.04M
-49.84%8.81M
-29.23%14.27M
-12.10%15.55M
-15.72%15.4M
-12.69%73.7M
-23.47%17.56M
0.57%20.17M
-22.88%17.69M
-1.01%18.28M
Operating profit
10.33%-69.97M
41.77%-11.95M
18.18%-17.47M
-12.36%-21.37M
-11.92%-19.18M
-23.43%-78.03M
2.07%-20.52M
-21.35%-21.35M
-36.83%-19.02M
-59.10%-17.14M
Net non-operating interest income expense
23.31%6.45M
0.91%1.43M
18.65%1.72M
39.15%1.8M
40.28%1.5M
1,022.10%5.23M
124.13%1.42M
446.42%1.45M
1,600.00%1.29M
408.36%1.07M
Non-operating interest income
15.77%6.59M
-0.07%1.46M
16.93%1.75M
25.19%1.83M
21.85%1.55M
159.49%5.69M
55.36%1.47M
115.27%1.49M
268.94%1.46M
697.48%1.27M
Non-operating interest expense
-70.15%137K
-31.82%30K
-36.96%29K
-80.12%34K
-77.78%44K
-73.41%459K
-85.76%44K
-89.28%46K
-64.52%171K
-60.87%198K
Other net income (expense)
-14,431.82%-6.39M
-847.42%-2.02M
-1,891.96%-3.96M
-134.38%-219K
28.25%-193K
98.05%-44K
86.79%-213K
15.68%-199K
410.73%637K
-33.83%-269K
Gain on sale of security
-296.00%-49K
-335.71%-33K
-16.67%5K
-900.00%-8K
-425.00%-13K
213.64%25K
450.00%14K
128.57%6K
-66.67%1K
--4K
Special income (charges)
-9,095.65%-6.35M
-774.45%-1.99M
-1,836.10%-3.97M
-133.18%-211K
34.07%-180K
96.91%-69K
85.89%-227K
4.65%-205K
405.77%636K
-35.82%-273K
-Less：Restructuring and merger&acquisition
9,095.65%6.35M
774.45%1.99M
1,836.10%3.97M
133.18%211K
-34.07%180K
-96.91%69K
-85.89%227K
-4.65%205K
-405.77%-636K
35.82%273K
Income before tax
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
-12.05%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-44.32%-16.34M
Income tax
0
0
Net income
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
Net income continuous Operations
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
Minority interest income
Net income attributable to the parent company
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
Basic earnings per share
13.64%-0.38
41.67%-0.07
16.67%-0.1
-10.00%-0.11
0.00%-0.1
4.35%-0.44
14.29%-0.12
0.00%-0.12
0.00%-0.1
9.09%-0.1
Diluted earnings per share
13.64%-0.38
41.67%-0.07
16.67%-0.1
-10.00%-0.11
0.00%-0.1
4.35%-0.44
14.29%-0.12
0.00%-0.12
0.00%-0.1
9.09%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -65.98%6.17M-26.62%1.57M-71.25%1.34M-62.89%1.73M-77.09%1.53M-53.51%18.14M-65.65%2.15M-21.74%4.66M-67.34%4.65M-46.85%6.69M
Operating revenue -65.98%6.17M-26.62%1.57M-71.25%1.34M-62.89%1.73M-77.09%1.53M-53.51%18.14M-65.65%2.15M-21.74%4.66M-67.34%4.65M-46.85%6.69M
Cost of revenue
Gross profit
Operating expense -20.83%76.15M-40.34%13.52M-27.68%18.81M-2.42%23.1M-13.06%20.72M-5.93%96.18M-16.67%22.67M10.46%26.01M-15.88%23.67M2.03%23.83M
Selling and administrative expenses -1.63%22.11M-7.63%4.71M-22.34%4.54M26.20%7.55M-4.32%5.31M26.02%22.48M20.05%5.1M67.25%5.84M15.00%5.98M13.49%5.55M
-General and administrative expense -1.63%22.11M-7.63%4.71M-22.34%4.54M26.20%7.55M-4.32%5.31M26.02%22.48M20.05%5.1M67.25%5.84M15.00%5.98M13.49%5.55M
Research and development costs -26.68%54.04M-49.84%8.81M-29.23%14.27M-12.10%15.55M-15.72%15.4M-12.69%73.7M-23.47%17.56M0.57%20.17M-22.88%17.69M-1.01%18.28M
Operating profit 10.33%-69.97M41.77%-11.95M18.18%-17.47M-12.36%-21.37M-11.92%-19.18M-23.43%-78.03M2.07%-20.52M-21.35%-21.35M-36.83%-19.02M-59.10%-17.14M
Net non-operating interest income expense 23.31%6.45M0.91%1.43M18.65%1.72M39.15%1.8M40.28%1.5M1,022.10%5.23M124.13%1.42M446.42%1.45M1,600.00%1.29M408.36%1.07M
Non-operating interest income 15.77%6.59M-0.07%1.46M16.93%1.75M25.19%1.83M21.85%1.55M159.49%5.69M55.36%1.47M115.27%1.49M268.94%1.46M697.48%1.27M
Non-operating interest expense -70.15%137K-31.82%30K-36.96%29K-80.12%34K-77.78%44K-73.41%459K-85.76%44K-89.28%46K-64.52%171K-60.87%198K
Other net income (expense) -14,431.82%-6.39M-847.42%-2.02M-1,891.96%-3.96M-134.38%-219K28.25%-193K98.05%-44K86.79%-213K15.68%-199K410.73%637K-33.83%-269K
Gain on sale of security -296.00%-49K-335.71%-33K-16.67%5K-900.00%-8K-425.00%-13K213.64%25K450.00%14K128.57%6K-66.67%1K--4K
Special income (charges) -9,095.65%-6.35M-774.45%-1.99M-1,836.10%-3.97M-133.18%-211K34.07%-180K96.91%-69K85.89%-227K4.65%-205K405.77%636K-35.82%-273K
-Less：Restructuring and merger&acquisition 9,095.65%6.35M774.45%1.99M1,836.10%3.97M133.18%211K-34.07%180K-96.91%69K-85.89%227K-4.65%205K-405.77%-636K35.82%273K
Income before tax 4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M-12.05%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-44.32%-16.34M
Income tax 00
Net income 4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M
Net income continuous Operations 4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M
Minority interest income
Net income attributable to the parent company 4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M
Basic earnings per share 13.64%-0.3841.67%-0.0716.67%-0.1-10.00%-0.110.00%-0.14.35%-0.4414.29%-0.120.00%-0.120.00%-0.19.09%-0.1
Diluted earnings per share 13.64%-0.3841.67%-0.0716.67%-0.1-10.00%-0.110.00%-0.14.35%-0.4414.29%-0.120.00%-0.120.00%-0.19.09%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 11.940
Sample Name
Sample Code
 27.600
Sample Name
Sample Code
 12.100
4
Workday
WDAY
243.390
5
eBay
EBAY
67.200
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 381.450
Sample Name
Sample Code
 292.030
Sample Name
Sample Code
 14.220
4
Meta Platforms
META
554.440
5
Salesforce
CRM
267.760
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 292.030
Sample Name
Sample Code
 1125.640
Sample Name
Sample Code
 91.170
4
Cisco
CSCO
57.340
5
Meta Platforms
META
554.440
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.4405
Sample Name
Sample Code
 2.110
Sample Name
Sample Code
 0.1650
4
BTCS Inc
BTCS
1.790
5
MARA Holdings
MARA
14.220
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -